Ignite Creation Date:
2024-05-06 @ 10:26 AM
Last Modification Date:
2024-10-26 @ 12:29 PM
Study NCT ID:
NCT03250338
Status:
UNKNOWN
Last Update Posted:
2021-04-30
First Post:
2017-08-11
Brief Title:
Study Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in RR FLT3 Mutated AML
Sponsor:
Arog Pharmaceuticals Inc
Organization:
Arog Pharmaceuticals Inc
Organization Data
Organization:
Arog Pharmaceuticals Inc
Class:
INDUSTRY
Study ID:
ARO-013
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Arog Pharmaceuticals Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None